• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Commun Signal . SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells

tetano

Editor, Senior Moderator
Cell Commun Signal


. 2024 Jan 15;22(1):38.
doi: 10.1186/s12964-023-01397-6. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells

Alicia Villacampa[SUP] #[/SUP][SUP] 1 [/SUP], Enrique Alfaro[SUP] #[/SUP][SUP] 2 3 [/SUP], Cristina Morales[SUP] 1 [/SUP], Elena Díaz-García[SUP] 2 3 [/SUP], Cristina López-Fernández[SUP] 2 [/SUP], José Luis Bartha[SUP] 4 5 [/SUP], Francisco López-Sánchez[SUP] 5 [/SUP], Óscar Lorenzo[SUP] 6 7 8 [/SUP], Salvador Moncada[SUP] 1 [/SUP], Carlos F Sánchez-Ferrer[SUP] 1 9 [/SUP], Francisco García-Río[SUP] 2 3 8 [/SUP], Carolina Cubillos-Zapata[SUP] 2 3 [/SUP], Concepción Peiró[SUP] 10 11 [/SUP]



Affiliations
Free PMC article Abstract

Background: Hyperinflammation, hypercoagulation and endothelial injury are major findings in acute and post-COVID-19. The SARS-CoV-2 S protein has been detected as an isolated element in human tissues reservoirs and is the main product of mRNA COVID-19 vaccines. We investigated whether the S protein alone triggers pro-inflammatory and pro-coagulant responses in primary cultures of two cell types deeply affected by SARS-CoV-2, such are monocytes and endothelial cells.
Methods: In human umbilical vein endothelial cells (HUVEC) and monocytes, the components of NF-κB and the NLRP3 inflammasome system, as well as coagulation regulators, were assessed by qRT-PCR, Western blot, flow cytometry, or indirect immunofluorescence.
Results: S protein activated NF-κB, promoted pro-inflammatory cytokines release, and triggered the priming and activation of the NLRP3 inflammasome system resulting in mature IL-1β formation in both cell types. This was paralleled by enhanced production of coagulation factors such as von Willebrand factor (vWF), factor VIII or tissue factor, that was mediated, at least in part, by IL-1β. Additionally, S protein failed to enhance ADAMTS-13 levels to counteract the pro-coagulant activity of vWF multimers. Monocytes and HUVEC barely expressed angiotensin-converting enzyme-2. Pharmacological approaches and gene silencing showed that TLR4 receptors mediated the effects of S protein in monocytes, but not in HUVEC.
Conclusion: S protein behaves both as a pro-inflammatory and pro-coagulant stimulus in human monocytes and endothelial cells. Interfering with the receptors or signaling pathways evoked by the S protein may help preventing immune and vascular complications driven by such an isolated viral element. Video Abstract.

Keywords: Blood coagulation factors; Endothelial cells; Monocytes; NLRP3 inflammasome; SARS-CoV-2.

 
Back
Top Bottom